Literature DB >> 26965671

Alzheimer disease: Meta-analysis finds high reversion rate from MCI to normal cognition.

Heather Wood.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26965671     DOI: 10.1038/nrneurol.2016.29

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

Review 1.  Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis.

Authors:  Michael Malek-Ahmadi
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Oct-Dec       Impact factor: 2.703

  1 in total
  5 in total

Review 1.  Innate immune activation in Alzheimer's disease.

Authors:  Ming-Ming Wang; Dan Miao; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

2.  Out-of-Pocket Health Expenditures and Health Care Services Use Among Older Americans With Cognitive Impairment: Results From the 2008-2016 Health and Retirement Study.

Authors:  Derek Jenkins; Ariana Stickel; Hector M González; Wassim Tarraf
Journal:  Gerontologist       Date:  2022-07-15

3.  Effect of Process-Based Multi-Task Cognitive Training Program on Executive Function in Older Adults With Mild Cognitive Impairment: Study Rationale and Protocol Design for a Randomized Controlled Trial.

Authors:  Xia Zhao; Lina Wang; Chenxi Ge; Xiaoshen Liu; Mei Chen; Chen Zhang
Journal:  Front Psychiatry       Date:  2020-07-23       Impact factor: 4.157

Review 4.  An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.

Authors:  Hong-Feng Zhang; Li-Bo Huang; Yan-Biao Zhong; Qi-Hui Zhou; Hui-Lin Wang; Guo-Qing Zheng; Yan Lin
Journal:  Front Aging Neurosci       Date:  2016-12-06       Impact factor: 5.750

5.  Effects of exercise interventions for specific cognitive domains in old adults with mild cognitive impairment: A meta-analysis and subgroup analysis of randomized controlled trials.

Authors:  Xiang-Lian Zhou; Li-Na Wang; Jie Wang; Ling Zhou; Xin-Hua Shen
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.